K. Cusi

Epidemiology · 2012–2023

A researcher in the Science corpus: 11 papers; trusts 11 researchers and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 334 citations into it; #621 of 2,148 by trust here, #337 by citations
• Endocrinology, Diabetes and Metabolism — 228 citations into it; #232 of 623 by trust here, #165 by citations
• Hepatology — 174 citations into it
• Physiology — 54 citations into it; #1,089 of 2,276 by trust here, #1,497 by citations
• Pathology and Forensic Medicine — 44 citations into it
• Biochemistry — 17 citations into it

Whom K. Cusi trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. B. Neuschwander‐Tetri
2. Z. Younossi
3. E. Bugianesi
4. Ralph DeFronzo
5. A. Sanyal
6. G. Targher
7. C. Lumeng
8. S. Harrison
9. N. Chalasani
10. Herbert Tilg

Who trusts K. Cusi overall

1. Z. Younossi
2. Andreas L. Birkenfeld
3. N. Chalasani
4. Gerald I. Shulman
5. S. Bischoff

Papers from K. Cusi's perspective

Ordered by how strongly the researchers K. Cusi trusts endorse each paper. Same corpus, a different order for every researcher.

1. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
2. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome (Hepatology)
3. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. (New England Journal of Medicine)
4. ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS (Hepatology)
5. Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (Gastroenterology)
6. EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (Obesity Facts)
7. Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases
8. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the… (American Journal of Gastroenterology)
9. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The… (Journal of the American College of Cardiology)
10. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity (Annals medicus)

Their papers

• A multisociety Delphi consensus statement on new fatty liver disease nomenclature (2023) — 2,276 citations
• A multi-society Delphi consensus statement on new fatty liver disease nomenclature. (2023) — 2,621 citations
• American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). (2022) — 814 citations
• Advancing the global public health agenda for NAFLD: a consensus statement (2021) — 631 citations
• A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. (2020) — 1,488 citations
• Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. (2019) — 679 citations
• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018) — 6,253 citations
• Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus (2016) — 606 citations
• The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2012) — 2,216 citations
• Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. (2012) — 885 citations
• The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. (2012) — 1,723 citations